Clinical Trial Update: A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital) [EARLY_Phase 1]

View source ↗

Summary

Early-phase Phase 1 study evaluating GC101 Tumor-Infiltrating Lymphocytes for advanced hepatobiliary and pancreatic cancers, currently recruiting across 10 hosp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatobiliary Cancer
• Liver Cancer
• Pancreatic Cancer

Drugs mentioned

• GC101 TIL

Snippet

Sponsor: Shanghai Juncell Therapeutics | Conditions: Advanced Liver Cancers, Tumor Infiltrating Lymphocyte | EARLY_Phase 1 | Status: RECRUITING